Biomed Ltd., Manufacturer of Sera and Vaccines
PolandAll drugs from this manufacturer
-
The medicinal product is used to neutralize botulinum toxins of types A, B, and E in cases of botulism.
Dosage form: solution for injection
Active substance Dosage botulinum antitoxin monovalent a 5000 j. botulinum antitoxin monovalent b 5000 j. botulinum antitoxin monovalent e 1000 j. ATC: J06AA04
-
The medicinal product is used in individuals bitten by a viper to neutralize the toxic effects of the venom. It is particularly indicated in cases of severe poisoning.
Dosage form: solution for injection
Active substance Dosage anatoxin of the venom of the zigzag viper not less than 500 units LD50 ATC: J06AA03
-
It is used in cases of chronic adnexitis, infiltrative changes (including postoperative), endometritis, anal varices (hemorrhoids) in acute and chronic inflammatory states, as well as perirectal abscesses, fistulas with extensive inflammatory infiltration, and suppurating bursae in the coccygeal area.
Dosage form: suppositories
Active substance Dosage streptodornase 1250 j.m. streptokinase 15000 j.m. ATC: B01AD01
-
It is used in the case of oral and throat ulcers, oral wounds that are purulent, healing poorly, or have clots, as well as in purulent and inflammatory conditions of the tooth sockets and jaws following tooth extractions or other surgical procedures.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage streptokinase 15000 j.m. streptodornase 1250 j.m. ATC: B01AD01
-
The medicinal product is used to inhibit the anticoagulant effect of heparin.
Dosage form: solution for injection
Active substance Dosage protamine sulfate 50 mg/5 ml ATC: V03AB14
-
The vaccine is used to induce immunity against tetanus, a serious bacterial disease.
Dosage form: suspension for injection
Active substance Dosage tetanus toxoid not less than 40 IU ATC: J07AM01